Search for stock quotes, financial statistics and more
Raymond James analyst Michael W. Freeman thinks NervGen Pharma (NervGen Pharma Corp Stock Quote, Cha... Read More
Investors should be gearing up for some movement in the biotech space, says iA Capital Markets analy... Read More
iA Capital Markets analyst Chelsea Stellick likes the progress being made by clinical-stage biopharm... Read More
Paradigm Capital delivered a healthcare sector update on Wednesday on drug developer NervGen Pharma ... Read More
Even with a shake-up at the helm, it’s still full steam ahead for Canadian biopharmaceutical compa... Read More
Share
Tweet
pin
Share